Tuesday, 19 March, 2024
HomeInternationalBiotech wants emergency FDA approval for coronavirus test

Biotech wants emergency FDA approval for coronavirus test

Biotechnology company Novacyt has applied for emergency approval from the US Food and Drug Administration (FDA) as it races to roll out a product that tests for the coronavirus, reports Reuters Health. Novacyt, which is listed in Paris and London, also said it was in talks with public sector hospitals in Britain.

“As one of the first companies to develop and launch a test to detect the 2019 strain of nCoV (coronavirus), we have received unprecedented interest,” Novacyt CEO Graham Mullis said.

“We continue to support our new and existing customers and are working with the various regulatory authorities to try to make our nCoV test available to as many countries and laboratories as possible,” he added.

[link url="https://www.reuters.com/article/us-china-health-novacyt/biotech-company-novacyt-seeks-emergency-approval-for-coronavirus-test-idUSKBN2010Q8"]Full Reuters Health[/link]

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.